Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1988;35(6):651-6.
doi: 10.1007/BF00637602.

4-quinolones inhibit biotransformation of caffeine

Affiliations
Clinical Trial

4-quinolones inhibit biotransformation of caffeine

S Harder et al. Eur J Clin Pharmacol. 1988.

Erratum in

  • Eur J Clin Pharmacol 1989;36(1):100

Abstract

The pharmacokinetics of caffeine, including formation of its major metabolite paraxanthine in plasma, has been investigated in 12 healthy males (age 20-40 years) alone and during co-administration of the 4-quinolones ofloxacin, norfloxacin, pipemidic acid, ciprofloxacin, and enoxacin; ciprofloxacin and enoxacin were given in 3 different dose levels. The naphthyridine derivative enoxacin and the pyrido-pyrimidine derivative pipemidic acid had caused marked inhibition of caffeine and paraxanthine metabolism, whereas the genuine quinolone derivatives norfloxacin and ciprofloxacin had little effect, and the pyrido-benzoxacine derivative ofloxacin had no detectable effect. The different molecular and spatial structures of the compounds appear to be responsible for the differences in inhibitory potency.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Lancet. 1984 Jul 14;2(8394):108-9 - PubMed
    1. Chest. 1987 Oct;92(4):663-9 - PubMed
    1. N Engl J Med. 1987 Jul 9;317(2):117 - PubMed
    1. Br J Clin Pharmacol. 1981 Aug;12(2):155-9 - PubMed
    1. Dtsch Med Wochenschr. 1986 Sep 26;111(39):1500 - PubMed

Publication types

MeSH terms

LinkOut - more resources